SUMMARY A case of massive lower gastrointestinal bleeding from Crohn's disease is reported. This is an uncommon complication of the disease and the literature is reviewed. Successful control of gastrointestinal bleeding by intra-arterial vasopressin infusion has not previously been reported in Crohn's disease. We suggest that this technique may be used in an attempt to avoid surgery. Massive 11 .0 g/dl) and dehydrated (urea 32.5 mmol/l). Correction of fluid and electrolyte imbalance and administration of corticosteroids was associated with dramatic clinical improvement. Seven days after admission her recovery was interrupted by profuse rectal bleeding. During the following 24 hours, 4 1 of clot and dark red blood was passed, transfusion of 3.5 1 of blood being needed to maintain vital signs. Gastroduodenoscopy was normal and there was no evidence of a bleeding diathesis. Mesenteric angiography demonstrated extravasation of contrast from a branch of the left colic artery in the region of the splenic flexure ( Fig.  1 ). The angiographic catheter was left in position and used to selectively infuse a solution of vasopressin (0.1 units/min) into the inferior mesenteric artery. Angiography was repeated after 20 minutes, demonstrating generalised arterial constriction with cessation of bleeding (Fig. 2) . The infusion was changed to normal saline and the patient returned to the ward with the angiographic catheter in situ. Bleeding recurred 10 hours later but was quickly controlled by a further vasopressin infusion, which was, on this occasion, continued for 48 hours (0.2 units/min for 24 hours followed by 0.1 units/min for a further 24 hours) The catheter was removed without significant complication after four days. Subsequent colonoscopy confirmed colonic involvement, which was maximal at the splenic flexure. The patient has remained well, maintaining 
Discussion
Endoscopy is the primary investigation for acute gastrointestinal haemorrhage but, if this fails to identify the bleeding site, diagnostic angiography may be performed, although bleeding at a rate of at least 0.5 ml/min is necessary for successful visualisation. 5 With heavy bleeding sufficient contrast may extravasate to outline an ulcer or diverticulum or show the mucosal pattern of the bowel. In our patient, a crescent of contrast was seen on late films (Fig. lb) which was identical to the 'pseudovein' described by Ring et a16 and attributed to extravasated contrast being contained by blood clot. At the site of extravasation, the post-infusion films showed two small arterial branches with calibre irregularities (Fig. 2) . These vessels were presumed to be the origin of the bleed due to involvement in the inflammatory process.
Mesenteric arterial constriction in response to vasopressin infusion has been shown in early
Crohn's disease.7We were, however, cautious in our use of vasopressin, as it has been suggested that it might aggravate the intestinal ischaemia of established Crohn's disease and lead to bowel necrosis.2 In an attempt to avoid such problems, the initial vasopressin infusion was discontinued after 30 minutes and angiography had demonstrated cessation of bleeding. When further bleeding occurred, however, a prolonged vasopressin infusion was used accordinE to the regime recommended by Gordon et al. Our patient had a very long history of Crohn's disease, but colonic involvement was recent and could account for the excellent response which was seen.
Problems associated with angiographic control of intestinal bleeding include sepsis, arterial thrombosis, pseudo-aneurysm, and puncture site bleeding.8 All these are rare, with the exception of bleeding at the puncture site which can be easily controlled by manual compression. The pharmacological properties of vasopressin explain some of the complications of arterial infusion; bowel colic is common and can be minimised by slowly increasing the rate of infusion. Systemic effects such as myocardial ischaemia and fluid retention are unlikely to occur with the low dosage infused selectively in this manner.
This report shows that selective mesenteric arterial infusion of vasopressin may be successful in the management of massive lower gastrointestinal bleeding in Crohn's disease. 
